| Literature DB >> 35083854 |
Xavier Montagutelli1, Sylvie van der Werf2,3, Felix A Rey4, Etienne Simon-Loriere5.
Abstract
SARS-CoV-2 Omicron harbors substitutions in the receptor binding domain of the spike which strongly suggest its capacity to infect rodents. Wild animal reservoirs could favor the emergence of new variants with risks of spillback to humans and should be closely monitored.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35083854 PMCID: PMC8899904 DOI: 10.15252/emmm.202115558
Source DB: PubMed Journal: EMBO Mol Med ISSN: 1757-4676 Impact factor: 12.137
Figure 1Amino acid changes in the receptor–binding domain (RBD) of the spike of SARS‐CoV‐2
Residues 417, 493, 498, and 501 are also modified in several mouse‐adapted SARS‐CoV‐2 strains. A: Table of changes in section of the RBD for pandemic lineages and mouse‐adapted strains. B: Mapping onto the X‐ray structure of the RBD (PDB 6M0J) shown as a white surface with the human ACE2 contact area highlighted in yellow (left panels). The RBD residues recurrently observed as undergoing changes upon adaptation of SARS‐CoV‐2 to mice are marked in blue in the middle panels, while the multiple changes observed in the RBD of the Omicron variant spike are indicated in purple in the right panels. Mouse‐adapted strains: MACo3 from Montagutelli et al (preprint: Montagutelli et al, 2021a), WBP‐1 from Huang et al (2021), MASCp36 from Sun et al (2021), HRB26M, which also contains a deletion near the furin site, from Wang et al (2020) and MA10 from Leist et al (2020). Other changes outside of the RBD were also noted in mouse‐adapted SARS‐CoV‐2 genomes.